ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Ceftriaxone Sodium Market Research Report 2026
Published Date: 2026-02-13
|
Report Code: QYRE-Auto-28X8914
Home | Market Reports
Global Ceftriaxone Sodium Market Outlook 2022
BUY CHAPTERS

Global Ceftriaxone Sodium Market Research Report 2026

Code: QYRE-Auto-28X8914
Report
2026-02-13
Pages:123
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Shandong Ruiying
Qilu Antibiotics
Nectar Lifesciences
KELUN
United Laboratories
Aurobindo Pharma
Orchid Pharma
Medya Pharma
REYOUNG
LKPC
ACS Dobfar
NCPC
Dawnrays
Kopran

Ceftriaxone Sodium Market Size

The global Ceftriaxone Sodium market was valued at US$ 244 million in 2025 and is anticipated to reach US$ 202 million by 2032, at a CAGR of -2.7% from 2026 to 2032.

Ceftriaxone Sodium Market

Ceftriaxone Sodium Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Ceftriaxone Sodium competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Ceftriaxone Sodium is a broad-spectrum third-generation cephalosporin antibiotic that exerts bactericidal effects by inhibiting bacterial cell wall synthesis. It is indicated for the treatment of respiratory tract infections, urinary and reproductive system infections, skin and soft tissue infections, sepsis, and meningitis. The drug features a long half-life, sustained action, good tolerability, and can be administered via intravenous or intramuscular injection, making it widely applicable in clinical practice. In recent years, with increasing antibiotic resistance and the ongoing global burden of infectious diseases, the demand for ceftriaxone sodium in hospitals, community healthcare settings, and emergency infection control has grown steadily. Manufacturers have also optimized production processes and integrated raw materials to improve efficiency and product quality stability.In this report, we study the Ceftriaxone Sodium API.In 2024, global Ceftriaxone Sodium production reached approximately 2766 mt, with an average global market price of around US$ 94 per kg.
The global burden of infectious diseases continues to rise, particularly in developing countries and regions with aging populations, driving steady growth in demand for antibiotics and providing a strong growth impetus for the ceftriaxone sodium market. Governments are promoting policies for rational antibiotic use, insurance coverage, and updated clinical guidelines, encouraging hospitals to procure high-quality antibiotics. Annual reports indicate that leading pharmaceutical manufacturers continue to invest in raw material integration, capacity expansion, and development of new formulations to ensure supply stability and product diversity. Brokerage reports highlight that antimicrobial resistance control, community infection management, and standardized clinical usage trends will further increase market penetration of ceftriaxone sodium in hospitals and primary care facilities.
The ceftriaxone sodium industry faces challenges such as raw material price volatility, complex production processes, and strict international quality standards. Annual reports reveal that key raw materials are partially imported, and supply chain fluctuations may impact production stability. Antibiotic resistance issues, strengthened regulatory oversight, and centralized procurement or price caps may pressure mid- to low-end product margins. Cross-border market expansion must also navigate registration approvals, market access, and regulatory differences, increasing operational risks for enterprises.
Downstream demand from hospitals, community healthcare institutions, and public health departments shows stable growth with structural optimization. Clinicians prefer formulations suitable for long-term storage, flexible dosing regimens, and both intravenous and intramuscular administration to address different infection types and emergency scenarios. Brokerage reports indicate that with the promotion of rational antibiotic use, hospital medication standardization, and digital drug management systems, ceftriaxone sodium is expected to achieve higher clinical adherence and inventory efficiency, while high-end formulations and novel extended-release products may become key points of market differentiation in the future.
This report delivers a comprehensive overview of the global Ceftriaxone Sodium market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Ceftriaxone Sodium. The Ceftriaxone Sodium market size, estimates, and forecasts are provided in terms of sales volume (MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Ceftriaxone Sodium market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Ceftriaxone Sodium manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Ceftriaxone Sodium Market Report

Report Metric Details
Report Name Ceftriaxone Sodium Market
Accounted market size in 2025 US$ 244 million
Forecasted market size in 2032 US$ 202 million
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • ChP
  • USP
  • EP
by Application
  • Single Injection
  • Compound Injection
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Shandong Ruiying, Qilu Antibiotics, Nectar Lifesciences, Kelun, United Laboratories, Aurobindo Pharma, Orchid Pharma, Medya Pharma, REYOUNG, LKPC, ACS Dobfar, NCPC, Dawnrays, Kopran
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Ceftriaxone Sodium manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Ceftriaxone Sodium sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

What is the Ceftriaxone Sodium Market size in 2032?

Ans: The Ceftriaxone Sodium Market size in 2032 will be US$ 202 million.

Who are the main players in the Ceftriaxone Sodium Market report?

Ans: The main players in the Ceftriaxone Sodium Market are Shandong Ruiying, Qilu Antibiotics, Nectar Lifesciences, Kelun, United Laboratories, Aurobindo Pharma, Orchid Pharma, Medya Pharma, REYOUNG, LKPC, ACS Dobfar, NCPC, Dawnrays, Kopran

What are the Application segmentation covered in the Ceftriaxone Sodium Market report?

Ans: The Applications covered in the Ceftriaxone Sodium Market report are Single Injection, Compound Injection

What are the Type segmentation covered in the Ceftriaxone Sodium Market report?

Ans: The Types covered in the Ceftriaxone Sodium Market report are ChP, USP, EP

1 Ceftriaxone Sodium Market Overview
1.1 Product Definition
1.2 Ceftriaxone Sodium by Type
1.2.1 Global Ceftriaxone Sodium Market Value by Type: 2025 vs 2032
1.2.2 ChP
1.2.3 USP
1.2.4 EP
1.3 Ceftriaxone Sodium by Application
1.3.1 Global Ceftriaxone Sodium Market Value by Application: 2025 vs 2032
1.3.2 Single Injection
1.3.3 Compound Injection
1.4 Global Ceftriaxone Sodium Market Size Estimates and Forecasts
1.4.1 Global Ceftriaxone Sodium Revenue 2021–2032
1.4.2 Global Ceftriaxone Sodium Sales 2021–2032
1.4.3 Global Ceftriaxone Sodium Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Ceftriaxone Sodium Market Competition by Manufacturers
2.1 Global Ceftriaxone Sodium Sales Market Share by Manufacturers (2021–2026)
2.2 Global Ceftriaxone Sodium Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Ceftriaxone Sodium Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Ceftriaxone Sodium, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Ceftriaxone Sodium, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Ceftriaxone Sodium, Product Types and Applications
2.7 Global Key Manufacturers of Ceftriaxone Sodium, Date of Entry into the Industry
2.8 Global Ceftriaxone Sodium Market Competitive Situation and Trends
2.8.1 Global Ceftriaxone Sodium Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Ceftriaxone Sodium Players Market Share by Revenue
2.8.3 Global Ceftriaxone Sodium Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Ceftriaxone Sodium Market Scenario by Region
3.1 Global Ceftriaxone Sodium Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Ceftriaxone Sodium Sales by Region: 2021–2032
3.2.1 Global Ceftriaxone Sodium Sales by Region: 2021–2026
3.2.2 Global Ceftriaxone Sodium Sales by Region: 2027–2032
3.3 Global Ceftriaxone Sodium Revenue by Region: 2021–2032
3.3.1 Global Ceftriaxone Sodium Revenue by Region: 2021–2026
3.3.2 Global Ceftriaxone Sodium Revenue by Region: 2027–2032
3.4 North America Ceftriaxone Sodium Market Facts & Figures by Country
3.4.1 North America Ceftriaxone Sodium Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Ceftriaxone Sodium Sales by Country (2021–2032)
3.4.3 North America Ceftriaxone Sodium Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Ceftriaxone Sodium Market Facts & Figures by Country
3.5.1 Europe Ceftriaxone Sodium Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Ceftriaxone Sodium Sales by Country (2021–2032)
3.5.3 Europe Ceftriaxone Sodium Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ceftriaxone Sodium Market Facts & Figures by Region
3.6.1 Asia Pacific Ceftriaxone Sodium Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Ceftriaxone Sodium Sales by Region (2021–2032)
3.6.3 Asia Pacific Ceftriaxone Sodium Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Ceftriaxone Sodium Market Facts & Figures by Country
3.7.1 Latin America Ceftriaxone Sodium Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Ceftriaxone Sodium Sales by Country (2021–2032)
3.7.3 Latin America Ceftriaxone Sodium Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ceftriaxone Sodium Market Facts & Figures by Country
3.8.1 Middle East and Africa Ceftriaxone Sodium Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Ceftriaxone Sodium Sales by Country (2021–2032)
3.8.3 Middle East and Africa Ceftriaxone Sodium Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ceftriaxone Sodium Sales by Type (2021–2032)
4.1.1 Global Ceftriaxone Sodium Sales by Type (2021–2026)
4.1.2 Global Ceftriaxone Sodium Sales by Type (2027–2032)
4.1.3 Global Ceftriaxone Sodium Sales Market Share by Type (2021–2032)
4.2 Global Ceftriaxone Sodium Revenue by Type (2021–2032)
4.2.1 Global Ceftriaxone Sodium Revenue by Type (2021–2026)
4.2.2 Global Ceftriaxone Sodium Revenue by Type (2027–2032)
4.2.3 Global Ceftriaxone Sodium Revenue Market Share by Type (2021–2032)
4.3 Global Ceftriaxone Sodium Price by Type (2021–2032)
5 Segment by Application
5.1 Global Ceftriaxone Sodium Sales by Application (2021–2032)
5.1.1 Global Ceftriaxone Sodium Sales by Application (2021–2026)
5.1.2 Global Ceftriaxone Sodium Sales by Application (2027–2032)
5.1.3 Global Ceftriaxone Sodium Sales Market Share by Application (2021–2032)
5.2 Global Ceftriaxone Sodium Revenue by Application (2021–2032)
5.2.1 Global Ceftriaxone Sodium Revenue by Application (2021–2026)
5.2.2 Global Ceftriaxone Sodium Revenue by Application (2027–2032)
5.2.3 Global Ceftriaxone Sodium Revenue Market Share by Application (2021–2032)
5.3 Global Ceftriaxone Sodium Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Shandong Ruiying
6.1.1 Shandong Ruiying Company Information
6.1.2 Shandong Ruiying Description and Business Overview
6.1.3 Shandong Ruiying Ceftriaxone Sodium Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Shandong Ruiying Ceftriaxone Sodium Product Portfolio
6.1.5 Shandong Ruiying Recent Developments/Updates
6.2 Qilu Antibiotics
6.2.1 Qilu Antibiotics Company Information
6.2.2 Qilu Antibiotics Description and Business Overview
6.2.3 Qilu Antibiotics Ceftriaxone Sodium Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Qilu Antibiotics Ceftriaxone Sodium Product Portfolio
6.2.5 Qilu Antibiotics Recent Developments/Updates
6.3 Nectar Lifesciences
6.3.1 Nectar Lifesciences Company Information
6.3.2 Nectar Lifesciences Description and Business Overview
6.3.3 Nectar Lifesciences Ceftriaxone Sodium Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Nectar Lifesciences Ceftriaxone Sodium Product Portfolio
6.3.5 Nectar Lifesciences Recent Developments/Updates
6.4 Kelun
6.4.1 Kelun Company Information
6.4.2 Kelun Description and Business Overview
6.4.3 Kelun Ceftriaxone Sodium Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Kelun Ceftriaxone Sodium Product Portfolio
6.4.5 Kelun Recent Developments/Updates
6.5 United Laboratories
6.5.1 United Laboratories Company Information
6.5.2 United Laboratories Description and Business Overview
6.5.3 United Laboratories Ceftriaxone Sodium Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 United Laboratories Ceftriaxone Sodium Product Portfolio
6.5.5 United Laboratories Recent Developments/Updates
6.6 Aurobindo Pharma
6.6.1 Aurobindo Pharma Company Information
6.6.2 Aurobindo Pharma Description and Business Overview
6.6.3 Aurobindo Pharma Ceftriaxone Sodium Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Aurobindo Pharma Ceftriaxone Sodium Product Portfolio
6.6.5 Aurobindo Pharma Recent Developments/Updates
6.7 Orchid Pharma
6.7.1 Orchid Pharma Company Information
6.7.2 Orchid Pharma Description and Business Overview
6.7.3 Orchid Pharma Ceftriaxone Sodium Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Orchid Pharma Ceftriaxone Sodium Product Portfolio
6.7.5 Orchid Pharma Recent Developments/Updates
6.8 Medya Pharma
6.8.1 Medya Pharma Company Information
6.8.2 Medya Pharma Description and Business Overview
6.8.3 Medya Pharma Ceftriaxone Sodium Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Medya Pharma Ceftriaxone Sodium Product Portfolio
6.8.5 Medya Pharma Recent Developments/Updates
6.9 REYOUNG
6.9.1 REYOUNG Company Information
6.9.2 REYOUNG Description and Business Overview
6.9.3 REYOUNG Ceftriaxone Sodium Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 REYOUNG Ceftriaxone Sodium Product Portfolio
6.9.5 REYOUNG Recent Developments/Updates
6.10 LKPC
6.10.1 LKPC Company Information
6.10.2 LKPC Description and Business Overview
6.10.3 LKPC Ceftriaxone Sodium Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 LKPC Ceftriaxone Sodium Product Portfolio
6.10.5 LKPC Recent Developments/Updates
6.11 ACS Dobfar
6.11.1 ACS Dobfar Company Information
6.11.2 ACS Dobfar Description and Business Overview
6.11.3 ACS Dobfar Ceftriaxone Sodium Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 ACS Dobfar Ceftriaxone Sodium Product Portfolio
6.11.5 ACS Dobfar Recent Developments/Updates
6.12 NCPC
6.12.1 NCPC Company Information
6.12.2 NCPC Description and Business Overview
6.12.3 NCPC Ceftriaxone Sodium Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 NCPC Ceftriaxone Sodium Product Portfolio
6.12.5 NCPC Recent Developments/Updates
6.13 Dawnrays
6.13.1 Dawnrays Company Information
6.13.2 Dawnrays Description and Business Overview
6.13.3 Dawnrays Ceftriaxone Sodium Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Dawnrays Ceftriaxone Sodium Product Portfolio
6.13.5 Dawnrays Recent Developments/Updates
6.14 Kopran
6.14.1 Kopran Company Information
6.14.2 Kopran Description and Business Overview
6.14.3 Kopran Ceftriaxone Sodium Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Kopran Ceftriaxone Sodium Product Portfolio
6.14.5 Kopran Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ceftriaxone Sodium Industry Chain Analysis
7.2 Ceftriaxone Sodium Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ceftriaxone Sodium Production Mode & Process Analysis
7.4 Ceftriaxone Sodium Sales and Marketing
7.4.1 Ceftriaxone Sodium Sales Channels
7.4.2 Ceftriaxone Sodium Distributors
7.5 Ceftriaxone Sodium Customer Analysis
8 Ceftriaxone Sodium Market Dynamics
8.1 Ceftriaxone Sodium Industry Trends
8.2 Ceftriaxone Sodium Market Drivers
8.3 Ceftriaxone Sodium Market Challenges
8.4 Ceftriaxone Sodium Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Shandong Ruiying
Qilu Antibiotics
Nectar Lifesciences
KELUN
United Laboratories
Aurobindo Pharma
Orchid Pharma
Medya Pharma
REYOUNG
LKPC
ACS Dobfar
NCPC
Dawnrays
Kopran
List of Tables
 Table 1. Global Ceftriaxone Sodium Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Ceftriaxone Sodium Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Ceftriaxone Sodium Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Ceftriaxone Sodium Sales (MT) of Key Manufacturers (2021–2026)
 Table 5. Global Ceftriaxone Sodium Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Ceftriaxone Sodium Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Ceftriaxone Sodium Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Ceftriaxone Sodium Average Price (USD/Kg) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Ceftriaxone Sodium, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Ceftriaxone Sodium, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Ceftriaxone Sodium, Product Types and Applications
 Table 12. Global Key Manufacturers of Ceftriaxone Sodium, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Ceftriaxone Sodium Companies by Tier (Tier 1, Tier 2, Tier 3), based on Ceftriaxone Sodium Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Ceftriaxone Sodium Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Ceftriaxone Sodium Sales by Region (MT), 2021–2026
 Table 18. Global Ceftriaxone Sodium Sales Market Share by Region (2021–2026)
 Table 19. Global Ceftriaxone Sodium Sales by Region (MT), 2027–2032
 Table 20. Global Ceftriaxone Sodium Sales Market Share by Region (2027–2032)
 Table 21. Global Ceftriaxone Sodium Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Ceftriaxone Sodium Revenue Market Share by Region (2021–2026)
 Table 23. Global Ceftriaxone Sodium Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Ceftriaxone Sodium Revenue Market Share by Region (2027–2032)
 Table 25. North America Ceftriaxone Sodium Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Ceftriaxone Sodium Sales by Country (MT), 2021–2026
 Table 27. North America Ceftriaxone Sodium Sales by Country (MT), 2027–2032
 Table 28. North America Ceftriaxone Sodium Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Ceftriaxone Sodium Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Ceftriaxone Sodium Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Ceftriaxone Sodium Sales by Country (MT), 2021–2026
 Table 32. Europe Ceftriaxone Sodium Sales by Country (MT), 2027–2032
 Table 33. Europe Ceftriaxone Sodium Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Ceftriaxone Sodium Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Ceftriaxone Sodium Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Ceftriaxone Sodium Sales by Region (MT), 2021–2026
 Table 37. Asia Pacific Ceftriaxone Sodium Sales by Region (MT), 2027–2032
 Table 38. Asia Pacific Ceftriaxone Sodium Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Ceftriaxone Sodium Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Ceftriaxone Sodium Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Ceftriaxone Sodium Sales by Country (MT), 2021–2026
 Table 42. Latin America Ceftriaxone Sodium Sales by Country (MT), 2027–2032
 Table 43. Latin America Ceftriaxone Sodium Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Ceftriaxone Sodium Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Ceftriaxone Sodium Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Ceftriaxone Sodium Sales by Country (MT), 2021–2026
 Table 47. Middle East and Africa Ceftriaxone Sodium Sales by Country (MT), 2027–2032
 Table 48. Middle East and Africa Ceftriaxone Sodium Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Ceftriaxone Sodium Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Ceftriaxone Sodium Sales (MT) by Type (2021–2026)
 Table 51. Global Ceftriaxone Sodium Sales (MT) by Type (2027–2032)
 Table 52. Global Ceftriaxone Sodium Sales Market Share by Type (2021–2026)
 Table 53. Global Ceftriaxone Sodium Sales Market Share by Type (2027–2032)
 Table 54. Global Ceftriaxone Sodium Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Ceftriaxone Sodium Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Ceftriaxone Sodium Revenue Market Share by Type (2021–2026)
 Table 57. Global Ceftriaxone Sodium Revenue Market Share by Type (2027–2032)
 Table 58. Global Ceftriaxone Sodium Price (USD/Kg) by Type (2021–2026)
 Table 59. Global Ceftriaxone Sodium Price (USD/Kg) by Type (2027–2032)
 Table 60. Global Ceftriaxone Sodium Sales (MT) by Application (2021–2026)
 Table 61. Global Ceftriaxone Sodium Sales (MT) by Application (2027–2032)
 Table 62. Global Ceftriaxone Sodium Sales Market Share by Application (2021–2026)
 Table 63. Global Ceftriaxone Sodium Sales Market Share by Application (2027–2032)
 Table 64. Global Ceftriaxone Sodium Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Ceftriaxone Sodium Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Ceftriaxone Sodium Revenue Market Share by Application (2021–2026)
 Table 67. Global Ceftriaxone Sodium Revenue Market Share by Application (2027–2032)
 Table 68. Global Ceftriaxone Sodium Price (USD/Kg) by Application (2021–2026)
 Table 69. Global Ceftriaxone Sodium Price (USD/Kg) by Application (2027–2032)
 Table 70. Shandong Ruiying Company Information
 Table 71. Shandong Ruiying Description and Business Overview
 Table 72. Shandong Ruiying Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 73. Shandong Ruiying Ceftriaxone Sodium Product
 Table 74. Shandong Ruiying Recent Developments/Updates
 Table 75. Qilu Antibiotics Company Information
 Table 76. Qilu Antibiotics Description and Business Overview
 Table 77. Qilu Antibiotics Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 78. Qilu Antibiotics Ceftriaxone Sodium Product
 Table 79. Qilu Antibiotics Recent Developments/Updates
 Table 80. Nectar Lifesciences Company Information
 Table 81. Nectar Lifesciences Description and Business Overview
 Table 82. Nectar Lifesciences Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 83. Nectar Lifesciences Ceftriaxone Sodium Product
 Table 84. Nectar Lifesciences Recent Developments/Updates
 Table 85. Kelun Company Information
 Table 86. Kelun Description and Business Overview
 Table 87. Kelun Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 88. Kelun Ceftriaxone Sodium Product
 Table 89. Kelun Recent Developments/Updates
 Table 90. United Laboratories Company Information
 Table 91. United Laboratories Description and Business Overview
 Table 92. United Laboratories Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 93. United Laboratories Ceftriaxone Sodium Product
 Table 94. United Laboratories Recent Developments/Updates
 Table 95. Aurobindo Pharma Company Information
 Table 96. Aurobindo Pharma Description and Business Overview
 Table 97. Aurobindo Pharma Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 98. Aurobindo Pharma Ceftriaxone Sodium Product
 Table 99. Aurobindo Pharma Recent Developments/Updates
 Table 100. Orchid Pharma Company Information
 Table 101. Orchid Pharma Description and Business Overview
 Table 102. Orchid Pharma Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 103. Orchid Pharma Ceftriaxone Sodium Product
 Table 104. Orchid Pharma Recent Developments/Updates
 Table 105. Medya Pharma Company Information
 Table 106. Medya Pharma Description and Business Overview
 Table 107. Medya Pharma Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 108. Medya Pharma Ceftriaxone Sodium Product
 Table 109. Medya Pharma Recent Developments/Updates
 Table 110. REYOUNG Company Information
 Table 111. REYOUNG Description and Business Overview
 Table 112. REYOUNG Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 113. REYOUNG Ceftriaxone Sodium Product
 Table 114. REYOUNG Recent Developments/Updates
 Table 115. LKPC Company Information
 Table 116. LKPC Description and Business Overview
 Table 117. LKPC Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 118. LKPC Ceftriaxone Sodium Product
 Table 119. LKPC Recent Developments/Updates
 Table 120. ACS Dobfar Company Information
 Table 121. ACS Dobfar Description and Business Overview
 Table 122. ACS Dobfar Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 123. ACS Dobfar Ceftriaxone Sodium Product
 Table 124. ACS Dobfar Recent Developments/Updates
 Table 125. NCPC Company Information
 Table 126. NCPC Description and Business Overview
 Table 127. NCPC Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 128. NCPC Ceftriaxone Sodium Product
 Table 129. NCPC Recent Developments/Updates
 Table 130. Dawnrays Company Information
 Table 131. Dawnrays Description and Business Overview
 Table 132. Dawnrays Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 133. Dawnrays Ceftriaxone Sodium Product
 Table 134. Dawnrays Recent Developments/Updates
 Table 135. Kopran Company Information
 Table 136. Kopran Description and Business Overview
 Table 137. Kopran Ceftriaxone Sodium Sales (MT), Revenue (US$ Million), Price (USD/Kg), and Gross Margin (2021–2026)
 Table 138. Kopran Ceftriaxone Sodium Product
 Table 139. Kopran Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Ceftriaxone Sodium Distributors List
 Table 143. Ceftriaxone Sodium Customers List
 Table 144. Ceftriaxone Sodium Market Trends
 Table 145. Ceftriaxone Sodium Market Drivers
 Table 146. Ceftriaxone Sodium Market Challenges
 Table 147. Ceftriaxone Sodium Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Ceftriaxone Sodium
 Figure 2. Global Ceftriaxone Sodium Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Ceftriaxone Sodium Market Share by Type: 2025 & 2032
 Figure 4. ChP Product Picture
 Figure 5. USP Product Picture
 Figure 6. EP Product Picture
 Figure 7. Global Ceftriaxone Sodium Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Ceftriaxone Sodium Market Share by Application: 2025 & 2032
 Figure 9. Single Injection
 Figure 10. Compound Injection
 Figure 11. Global Ceftriaxone Sodium Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Ceftriaxone Sodium Market Size (US$ Million), 2021–2032
 Figure 13. Global Ceftriaxone Sodium Sales (MT), 2021–2032
 Figure 14. Global Ceftriaxone Sodium Average Price (USD/Kg), 2021–2032
 Figure 15. Ceftriaxone Sodium Report Years Considered
 Figure 16. Ceftriaxone Sodium Sales Share by Manufacturers in 2025
 Figure 17. Global Ceftriaxone Sodium Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Ceftriaxone Sodium Players: Market Share by Revenue in Ceftriaxone Sodium in 2025
 Figure 19. Ceftriaxone Sodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Ceftriaxone Sodium Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Ceftriaxone Sodium Sales Market Share by Country (2021–2032)
 Figure 22. North America Ceftriaxone Sodium Revenue Market Share by Country (2021–2032)
 Figure 23. U.S. Ceftriaxone Sodium Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Ceftriaxone Sodium Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Ceftriaxone Sodium Sales Market Share by Country (2021–2032)
 Figure 26. Europe Ceftriaxone Sodium Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Ceftriaxone Sodium Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Ceftriaxone Sodium Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Ceftriaxone Sodium Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Ceftriaxone Sodium Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Ceftriaxone Sodium Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Ceftriaxone Sodium Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Ceftriaxone Sodium Revenue Market Share by Region (2021–2032)
 Figure 34. China Ceftriaxone Sodium Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Ceftriaxone Sodium Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Ceftriaxone Sodium Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Ceftriaxone Sodium Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Ceftriaxone Sodium Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Taiwan Ceftriaxone Sodium Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Indonesia Ceftriaxone Sodium Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Thailand Ceftriaxone Sodium Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Malaysia Ceftriaxone Sodium Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Philippines Ceftriaxone Sodium Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Ceftriaxone Sodium Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Ceftriaxone Sodium Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Ceftriaxone Sodium Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Ceftriaxone Sodium Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Ceftriaxone Sodium Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Ceftriaxone Sodium Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Ceftriaxone Sodium Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Ceftriaxone Sodium Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Ceftriaxone Sodium Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Ceftriaxone Sodium Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Ceftriaxone Sodium by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Ceftriaxone Sodium by Type (2021–2032)
 Figure 56. Global Ceftriaxone Sodium Price (USD/Kg) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Ceftriaxone Sodium by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Ceftriaxone Sodium by Application (2021–2032)
 Figure 59. Global Ceftriaxone Sodium Price (USD/Kg) by Application (2021–2032)
 Figure 60. Ceftriaxone Sodium Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Ceftriaxone Market Research Report 2025
Global Cephalosporin Antibiotics API Market Research Report 2025
Global Cefotaxime Sodium Injection Market Research Report 2024
Cephalosporin API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ceftizole Sodium for Injection Market Research Report 2024
Ceftriaxone Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cefazolin Sodium Market Research Report 2024
Global Cefdizime Sodium Market Research Report 2024
Global Ceftezole Sodium API Market Research Report 2024
Global Ceftazidime Market Insights Forecast to 2030
Global Ceftizoxime Sodium API Market Research Report 2024
Global Mezlocillin Sodium API Market Research Report 2024
Cephalexine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Flucloxacillin Sodium Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cefotaxime Sodium for Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mezlocillin Sodium Reagent Market Research Report 2024
Methotrexate Sodium Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cefminox Sodium for Injection Market Research Report 2024
Cefoxitin Sodium API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Amoxicillin Sodium Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions